Beam Therapeutics
BEAM • NASDAQ
Beam Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Evans, with a market cap of $2.3B.
CEOJohn Evans
Next Earnings
Upcoming earnings announcement for Beam Therapeutics
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.96
Revenue Estimate
$15.7M
Earnings History
Past 12 earnings reports for Beam Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | -$0.10Est: -$1.12 | +91.1% | $114.1MEst: $13.6M | +736.1% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$1.10Est: -$1.01 | -8.9% | $9.7MEst: $12.8M | -24.4% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$1.00Est: -$1.07 | +6.5% | $8.5MEst: $13.5M | -37.2% | 10-Q |
| May 6, 2025 | Q1 2025 | -$1.24Est: -$1.17 | -6.0% | $7.5MEst: $14.7M | -49.1% | 10-Q |
| Feb 25, 2025 | Q4 2024 | -$1.09Est: -$1.28 | +14.8% | $30.1MEst: $15.1M | +98.9% | 10-K |
| Nov 5, 2024 | Q3 2024 | -$1.17Est: -$1.16 | -0.9% | $14.3MEst: $14.5M | -1.6% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$1.11Est: -$1.14 | +2.6% | $11.8MEst: $13.7M | -14.3% | 10-Q |
| May 7, 2024 | Q1 2024 | -$1.21Est: -$1.42 | +14.8% | $7.4MEst: $17.0M | -56.3% | 10-Q |
| Feb 27, 2024 | Q4 2023 | $1.73Est: -$1.01 | +271.3% | $316.2MEst: $18.7M | +1593.6% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$1.22Est: -$1.34 | +9.0% | $17.2MEst: $17.5M | -1.7% | — |
| Aug 8, 2023 | Q2 2023 | -$1.08Est: -$1.42 | +23.9% | $20.1MEst: $18.1M | +11.4% | 10-Q |
| May 10, 2023 | Q1 2023 | -$1.33Est: -$1.34 | +0.7% | $24.2MEst: $14.1M | +71.9% | — |